Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity.

Benencia, Fabian

Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity. [electronic resource] - Cancer biology & therapy Jul 2006 - 867-74 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1538-4047

10.4161/cbt.5.7.2908 doi


Adenocarcinoma--drug therapy
Animals
Antigens, Neoplasm--immunology
Cancer Vaccines--immunology
Dendritic Cells--immunology
Disease Models, Animal
Female
Immediate-Early Proteins--genetics
Membrane Glycoproteins--immunology
Mice
Ovarian Neoplasms--drug therapy
Simplexvirus--genetics
T-Lymphocytes--immunology
Up-Regulation
Vaccination--methods
Virus Replication--genetics